Lead sponsor
Axon Neuroscience SE
4 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
4
Trials led
0
Ongoing
296
Total enrollment
49
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
3
Phase 2
1
Trials by status
Completed
3
Unknown
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's DiseaseAlzheimer's diseasePh 1Completed30